BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37163949)

  • 1. Scaffold hopping of N-benzyl-3,4,5-trimethoxyaniline: 5,6,7-Trimethoxyflavan derivatives as novel potential anticancer agents modulating hippo signaling pathway.
    Hassan AHE; Wang CY; Lee HJ; Jung SJ; Kim YJ; Cho SB; Lee CH; Ham G; Oh T; Lee SK; Lee YS
    Eur J Med Chem; 2023 Aug; 256():115421. PubMed ID: 37163949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The (+)-Brevipolide H Displays Anticancer Activity against Human Castration-Resistant Prostate Cancer: The Role of Oxidative Stress and Akt/mTOR/p70S6K-Dependent Pathways in G1 Checkpoint Arrest and Apoptosis.
    Sheng YH; Leu WJ; Chen CN; Hsu JL; Liu YT; Hsu LC; Hou DR; Guh JH
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32630532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3Kγ mediated PI3K/AKT/mTOR/p70S6K/ULK signaling pathway in human breast cancer cells.
    Zhang HW; Hu JJ; Fu RQ; Liu X; Zhang YH; Li J; Liu L; Li YN; Deng Q; Luo QS; Ouyang Q; Gao N
    Sci Rep; 2018 Jul; 8(1):11255. PubMed ID: 30050147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteoloside induces G
    Zhou M; Shen S; Zhao X; Gong X
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivated Sendai virus induces apoptosis and autophagy via the PI3K/Akt/mTOR/p70S6K pathway in human non-small cell lung cancer cells.
    Zhang Q; Zhu H; Xu X; Li L; Tan H; Cai X
    Biochem Biophys Res Commun; 2015 Sep; 465(1):64-70. PubMed ID: 26235873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.
    Kling MJ; Griggs CN; McIntyre EM; Alexander G; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
    BMC Cancer; 2021 Sep; 21(1):1061. PubMed ID: 34565342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doubling down on the PI3K-AKT-mTOR pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-ness.
    De P; Sun Y; Carlson JH; Friedman LS; Leyland-Jones BR; Dey N
    Neoplasia; 2014 Jan; 16(1):43-72. PubMed ID: 24563619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apigetrin induces extrinsic apoptosis, autophagy and G2/M phase cell cycle arrest through PI3K/AKT/mTOR pathway in AGS human gastric cancer cell.
    Kim SM; Vetrivel P; Ha SE; Kim HH; Kim JA; Kim GS
    J Nutr Biochem; 2020 Sep; 83():108427. PubMed ID: 32559585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Li YJ; Wang Y; Wang YY
    J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzo[b]furan derivatives induces apoptosis by targeting the PI3K/Akt/mTOR signaling pathway in human breast cancer cells.
    Kamal A; Lakshma Nayak V; Nagesh N; Vishnuvardhan MV; Subba Reddy NV
    Bioorg Chem; 2016 Jun; 66():124-31. PubMed ID: 27149364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anticancer effects of Cucurbitacin I inhibited cell growth of human non‑small cell lung cancer through PI3K/AKT/p70S6K pathway.
    Zhu X; Huang H; Zhang J; Liu H; Ao R; Xiao M; Wu Y
    Mol Med Rep; 2018 Feb; 17(2):2750-2756. PubMed ID: 29207097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isorhamnetin induces cell cycle arrest and apoptosis by triggering DNA damage and regulating the AMPK/mTOR/p70S6K signaling pathway in doxorubicin-resistant breast cancer.
    Yang T; Xiao Y; Liu S; Luo F; Tang D; Yu Y; Xie Y
    Phytomedicine; 2023 Jun; 114():154780. PubMed ID: 37004402
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    An W; Zhang Y; Lai H; Zhang Y; Zhang H; Zhao G; Liu M; Li Y; Lin X; Cao S
    Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35730618
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways.
    Leu WJ; Swain ShP; Chan SH; Hsu JL; Liu SP; Chan ML; Yu CC; Hsu LC; Chou YL; Chang WL; Hou DR; Guh JH
    Oncotarget; 2016 Nov; 7(47):76995-77009. PubMed ID: 27769069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3K/Akt and mTOR/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosis.
    Faghiri Z; Bazan NG
    Exp Eye Res; 2010 Jun; 90(6):718-25. PubMed ID: 20230819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, anticancer evaluation and mechanism studies of novel indolequinone derivatives of ursolic acid.
    Wang WY; Wu WY; Li AL; Liu QS; Sun Y; Gu W
    Bioorg Chem; 2021 Apr; 109():104705. PubMed ID: 33618252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents
    Su Q; Xu B; Tian Z; Gong Z
    Acta Pharm; 2022 Sep; 72(3):389-402. PubMed ID: 36651540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenofibrate inhibits mTOR-p70S6K signaling and simultaneously induces cell death in human prostate cancer cells.
    Lian X; Gu J; Gao B; Li Y; Damodaran C; Wei W; Fu Y; Cai L
    Biochem Biophys Res Commun; 2018 Jan; 496(1):70-75. PubMed ID: 29305864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin enhanced the antitumor efficacy of oxaliplatin in cisplatin-resistant ovarian cancer cells A2780cis both in vitro and in vivo.
    Liu J; Zhang L; Zhang X; Xing X
    J Chemother; 2015; 27(6):358-64. PubMed ID: 25976336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paris saponin VII, a Hippo pathway activator, induces autophagy and exhibits therapeutic potential against human breast cancer cells.
    Xiang YC; Peng P; Liu XW; Jin X; Shen J; Zhang T; Zhang L; Wan F; Ren YL; Yu QQ; Zhao HZ; Si Y; Liu Y
    Acta Pharmacol Sin; 2022 Jun; 43(6):1568-1580. PubMed ID: 34522004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.